Profile data is unavailable for this security.
About the company
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.
- Revenue in USD (TTM)0.00
- Net income in USD-8.63m
- Incorporated2010
- Employees6.00
- LocationAmpio Pharmaceuticals Inc9800 Mount Pyramid Court, Suite 400ENGLEWOOD 80112United StatesUSA
- Phone+1 (720) 437-6500
- Fax+1 (720) 437-6501
- Websitehttps://ampiopharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adhera Therapeutics Inc | 0.00 | -4.61m | 57.77k | 1.00 | -- | -- | -- | -- | -1.12 | -1.12 | 0.00 | -5.10 | 0.00 | -- | -- | -- | -2,989.56 | -460.83 | -- | -- | -- | -- | -- | -12,489.02 | -- | -0.509 | -- | -- | -- | -- | 67.47 | -- | -- | -- |
Baudax Bio Inc | 310.00k | -25.83m | 113.34k | 9.00 | -- | -- | -- | 0.3656 | -17.25 | -9.17 | 0.0778 | -0.0985 | 0.0163 | -- | -- | 34,444.45 | -135.61 | -112.14 | -- | -192.87 | -1,445.81 | -- | -8,331.61 | -9,179.73 | -- | -- | 1.30 | -- | 17.50 | -- | -164.95 | -- | -56.52 | -- |
Ampio Pharmaceuticals Inc | 0.00 | -8.63m | 113.54k | 6.00 | -- | 0.0248 | -- | -- | -11.10 | -11.10 | 0.00 | 4.03 | 0.00 | -- | -- | 0.00 | -89.34 | -72.16 | -109.57 | -84.33 | -- | -- | -- | -- | 2.32 | -- | 0.00 | -- | -- | -- | 47.16 | -- | -- | -- |
Propanc Biopharma Inc | 0.00 | -2.46m | 159.58k | 1.00 | -- | -- | -- | -- | -0.3033 | -0.3033 | 0.00 | -0.0337 | 0.00 | -- | -- | -- | -2,440.90 | -4,945.87 | -- | -- | -- | -- | -- | -- | -- | -1.70 | -- | -- | -- | -- | -17.63 | -- | -- | -- |
ContraFect Corp | 0.00 | -24.14m | 161.64k | 23.00 | -- | -- | -- | -- | -19.25 | -19.25 | 0.00 | -0.538 | 0.00 | -- | -- | 0.00 | -150.12 | -74.17 | -- | -94.04 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -221.24 | -- | -- | -- |
Data as of Jul 05 2024. Currency figures normalised to Ampio Pharmaceuticals Inc's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
Virtu Americas LLCas of 31 Mar 2024 | 19.10k | 1.68% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 7.77k | 0.68% |
Tower Research Capital LLCas of 31 Mar 2024 | 3.54k | 0.31% |
CVA Family Office LLCas of 31 Mar 2024 | 3.15k | 0.28% |
UBS Securities LLCas of 31 Mar 2024 | 1.25k | 0.11% |
Cypress Capital Management LLC (Wyoming)as of 31 Mar 2024 | 461.00 | 0.04% |
Arbor Point Advisors LLCas of 31 Mar 2024 | 315.00 | 0.03% |
GHP Investment Advisors, Inc.as of 31 Mar 2024 | 300.00 | 0.03% |
Sunbelt Securities, Inc.as of 31 Mar 2024 | 206.00 | 0.02% |
JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024 | 101.00 | 0.01% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.